Company Filing History:
3 out of 3 
2 out of 83 
1 out of 93 
Years Active: 2022-2024
Title: Thomas Pietschmann: Innovator in Viral Research
Introduction
Thomas Pietschmann is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of infectious diseases, particularly in understanding and treating viral infections. With a total of 3 patents, his work has the potential to impact public health significantly.
Latest Patents
One of his latest patents focuses on diagnostics and therapy for human respiratory syncytial virus (HRSV). This invention pertains to a method for identifying genetic variants associated with the severity of HRSV infections, particularly in human infants. The genetic polymorphisms identified can be used for diagnostics and patient stratification, aiming to reduce fatal events during infection and to select the most appropriate therapeutic approaches.
Another notable patent involves repressors of viral infection. This invention describes a non-human genetically modified animal with increased susceptibility to human viruses. By genetically impairing the expression of specific viral infection repression factors, the invention enhances infection in non-human hosts. It also provides methods for generating such animals, increasing or reducing cell susceptibility to viral infections, and screening novel modulators for potential therapies, especially for hepatitis C.
Career Highlights
Throughout his career, Thomas Pietschmann has worked with esteemed organizations such as Twincore Zentrum für Experimentelle und Klinische Infektionsforschung GmbH and Medizinische Hochschule Hannover. His research has been pivotal in advancing our understanding of viral infections and developing innovative therapeutic strategies.
Collaborations
Some of his notable coworkers include Sibylle Haid and Daniel Todt. Their collaborative efforts have contributed to the success of his research and the development of his patents.
Conclusion
Thomas Pietschmann's innovative work in the field of viral research exemplifies the importance of scientific inquiry in addressing public health challenges. His patents and collaborations continue to pave the way for advancements in diagnostics and therapies for infectious diseases.